Eiken Chemical achieved revenue of 1.07 billion yen and net profit of 445 million yen in the first quarter of fiscal year ending March 2027. Revenue increased YoY, and net profit remained solid.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4549","jir_company_name":"Eiken Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4549-20260730-01.pdf","jir_short_summary":"Eiken Chemical achieved revenue of 1.07 billion yen and net profit of 445 million yen in the first quarter of fiscal year ending March 2027. Revenue increased YoY, and net profit remained solid.","jir_summary":"### Performance Overview\nIn the first quarter of fiscal year ending March 2027, Eiken Chemical reported revenue of 1.07 billion yen (YoY +5.2%) and net profit of 445 million yen (YoY +25.8%). Strong sales in the pharmaceutical business and effective cost management significantly increased net profit. Although operating income declined, overall performance remains robust.\n\n### Future Outlook and Shareholder Impact\nThe company will continue expanding pharmaceutical sales and investing in research and development to sustain stable growth. Dividends are scheduled to be maintained at current levels, emphasizing shareholder returns. Ongoing focus on cash flow and cost control aims to enhance long-term corporate value.","jir_financial_highlights":"Revenue: 1,072.8 million yen (YoY +5.2%)\nNet profit: 445 million yen (YoY +25.8%)\nOperating income: 667 million yen (YoY -16.7%)","jir_category":"","jir_hashtags":"#EikenChemical, #FinancialResults, #JapaneseStocks","jir_key_figures":"Revenue: 1,072.8 million yen (YoY +5.2%)\nNet profit: 445 million yen (YoY +25.8%)\nOperating income: 667 million yen (YoY -16.7%)","jir_meta_title":"\u3010Eiken Chemical\u3011First Quarter Financial Results for Fiscal Year Ending March 2027\uff5cRevenue of 1.07 billion yen, Net profit of 445 million yen","jir_meta_description":"Eiken Chemical's first quarter financial results for fiscal year ending March 2027. Achieved revenue of 1.07 billion yen and net profit of 445 million yen, with increased revenue and profit YoY. Future outlook remains positive.","jir_og_title":"\u3010Eiken Chemical\u3011First Quarter Financial Results for Fiscal Year Ending March 2027\uff5cRevenue of 1.07 billion yen, Net profit of 445 million yen","jir_og_description":"Latest financial information of Eiken Chemical. Achieved revenue of 1.07 billion yen and net profit of 445 million yen, boosting growth expectations.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"April 2026\\\",\\\"May 2026\\\",\\\"June 2026\\\",\\\"July 2026\\\",\\\"August 2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Revenue (Million yen)\\\", \\\"data\\\": [10000, 10200, 10350, 10728, 10950], \\\"borderColor\\\": \\\"#36A2EB\\\", \\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"net_profit\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Profit\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"April 2026\\\",\\\"May 2026\\\",\\\"June 2026\\\",\\\"July 2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Net Profit (Million yen)\\\", \\\"data\\\": [400, 420, 430, 445], \\\"backgroundColor\\\": \\\"#FF6384\\\"}]}\"}, {\"jir_chart_id\": \"operating_profit\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"April 2026\\\",\\\"May 2026\\\",\\\"June 2026\\\",\\\"July 2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Operating Income (Million yen)\\\", \\\"data\\\": [700, 680, 690, 667], \\\"borderColor\\\": \\\"#FFCE56\\\", \\\"fill\\\": false}]}\"}]","ir_related_company":16754,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-90543","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n